Royalty Pharma declares $0.235 dividend for Q4 2026, payable December 10

Royalty Pharma plc announced a dividend of $0.235 per Class A share for the fourth quarter of 2026. The dividend will be paid on December 10, 2026, to shareholders recorded by November 13, 2026. This payment reflects Royalty Pharma's ongoing commitment to returning value to shareholders amid its role as a major buyer of biopharmaceutical royalties. Investors can expect continued updates on the company's financial performance, with Q3 2026 results due November 4, 2026.

Royalty Pharma's Class A shares are trading at USD 59.66 on Pluang, showing a slight increase of 0.08% as of October 16, 2026, 19:11 WIB. The stock maintains a dividend yield of 1.58%, with a market cap of $26.55 billion at this time.